Wells Fargo’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Wells Fargo’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,822	Closed	-$97K	–	6651
2014 Q4	$97K	Buy	2,822 +9	+0.3%	+$294	﹤0.01%	4753
2014 Q3	$84K	Sell	2,813 -2,466	-47%	-$52.3K	﹤0.01%	4732
2014 Q2	$106K	Sell	5,279 -483,914	-99%	-$11.1M	﹤0.01%	4656
2014 Q1	$13.3M	Buy	489,193 +277,364	+131%	+$7.36M	0.01%	1573
2013 Q4	$4.39M	Buy	211,829 +27,843	+15%	+$525K	﹤0.01%	2343
2013 Q3	$3.35M	Buy	183,986 +115,938	+170%	+$2.09M	﹤0.01%	2501
2013 Q2	$1.13M	Buy	+68,048	New	+$1.09M	﹤0.01%	3200

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Wells Fargo's AUXL Position: Q1 2015 in Review

Wells Fargo sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 2,822 shares — an estimated $97K sold.

Wells Fargo first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $13.3M in Q1 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Wells Fargo reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Wells Fargo sold 2,822 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $97K.
Wells Fargo first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Wells Fargo's AUXILIUM PHARAMCEUTICALS INC position peaked at $13.3M in Q1 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Wells Fargo's 13F filing for Q1 2015, filed 12 May 2015.